- Chronic patient
Painkillers are widely used in chronic patients
Chronic patients use many pain relievers, but they do not have enough knowledge about it. This can cause serious side effects. This is evident from the annual Pijnpeiling of the Institute for Responsible Drug Use (IVM), commissioned by Centraal Bureau Drogisterijbedrijven (CBD). The vast majority should seek advice from experts in the store. A significant proportion of patients are not happy that paracetamol (1000 mg) should be paid until 1 January.
Painkillers are commonly used among chronic patients. The majority of the medical panel consists of people with chronic diseases. Half of the respondents, for example, use painkillers to buy themselves at the pharmacy. He knows that painkillers may have serious side effects, and that about half of them are not accurate when it comes to safe use of combinations of painkillers. According to Ruud Coolen van Brakel, the director of IVM, a picture of the hopeful view: "At the same time, a large number of the participants are open to advice from the chemist and are positive even if they are not."
Providing accurate information is a free case for painkillers.
Three quarters find it important that there are specialized staff in the pharmacy area to advise on the purchase and proper use of painkillers. And when the chemist warns about the risks (unwanted) almost 80% appreciate it. According to the majority of the panel, providing good information is an important condition for free availability of resources. This supports the argument of the IVM prohibiting the sale of heavy painkillers in supermarkets without an assistant pharmacy or drug store.
Paracetamol from insurance package
A significant number of chronic patients are unhappy with the fact that relatively safe painkiller paracetamol (1000 mg) is recovered from the insurance package on January 1st next year. If he used this medicine for more than a quarter of a time, he would ask for a remedy different or reimbursed from the doctor. If the doctor continues to do so, the use of more risky, more severe painkillers such as NSAIDs will increase.
The pharmaceutical industry thinks that the safe and accurate use of pain relievers is very important and that it has been examined for the second consecutive year. This year's focus is based not only on pain relievers, but also on the experience of seeing about the availability of pain relievers and pain relievers. Last year was the overestimation of their information and the risk of ignoring risks. This year, a large majority show that they need advice on the risks and side effects of the pharmacy.
Additional info …
For more information about this message, contact your source and / or provider. News may vary, may contain errors or inaccuracies. Also, please read our disclaimer and comply with our terms a.u.b. messages, responses and / or images.
Click the labels below for the corresponding messages.
- Photographer or photo agency :: ıngımages
- Source of this article: Institute for Responsible Drug Use
- What is the URL & # 39; s of this resource ?: https://www.medicijngebruik.nl/
- Original title: Pain Research 2018: a lot of doubt with correct use pain relievers
- Target group: Health workers
- history: 10/11/2018